Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06148545
Other study ID # UH23020108
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 30, 2023
Est. completion date September 29, 2023

Study information

Verified date November 2023
Source Hasanuddin University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Iron and vitamin D are two essential micronutrients for the normal growth of young children, and their deficiencies are still a major health problem in developing countries, including Indonesia. A significant association between vitamin D deficiency and anemia has been reported throughout the world. Several studies in various populations all over the world suggest a high degree of association between Iron deficiency anemia and vitamin D deficiency. It is still controversial which deficiency causes the other but this association should be addressed in view of a better treatment proposal. The aim of the present study was to determine the effect of vitamin D supplementation on iron status in iron deficiency anemia.


Description:

This research is a randomized controlled trial study conducted in Makassar, South of Sulawesi, Indonesia from April to October 2023. This study was conducted on children with a diagnosis of iron deficiency anemia. Patients were divided into two groups, namely group A which received standard therapy (Fe preparations) 3 mg/kgBW/day, and group B (which received standard therapy combination vitamin D, 400IU). The inclusion criteria in this study were children aged 1-5 years, diagnosed with iron deficiency anemia, and parents/caregivers willing to include their children in this study. Children who had received iron preparation, and previous blood transfusion were excluded in this study. Patients who refused blood tests after giving therapy for 4 weeks were declared dropouts. Researchers will provide informed consent to parents/caregivers of children who met the research criteria. Anamnesis, general physical examination, and complete blood count (CBC) analysis were carried out: hemoglobin (Hb), Red Blood cell (RBC), Mean erythrocyte volume (MCV), Mean erythrocyte hemoglobin (MCH), Reticulocytes, serum iron, and serum ferritin. Iron deficiency anemia if the level of hemoglobin <11 g/dL, microcytic Hypochromia, serum ferritin < 30 pg/dl, then given iron and vitamin D preparation for 4 weeks, then checked again complete blood count, serum fe and serum ferritin. The research results are recorded in a research form and the data is grouped and SPSS version 21.0 software is used for data analysis. A P value <0.05 was considered for statistical analysis. This study was approved by the ethics and research committee of the faculty of medicine, at Hasanuddin University


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date September 29, 2023
Est. primary completion date September 29, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Year to 5 Years
Eligibility Inclusion Criteria: 1. Clinical diagnosis of Children's Iron deficiency anemia 2. Must be able to drink syrups Exclusion Criteria: 1. Patients who have diarrhea 2. Patients who experience vomiting 3. Severe anemia 4. Post Transfusion

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Elemental iron
Group A who received standard therapy (Fe preparations) 3 mg/kg BW/day
Elemental iron and Vit D
Group B received standard therapy (Fe preparations) 3 mg/kgBW/day combination with vitamin D, 400IU).

Locations

Country Name City State
Indonesia Universitas Hasanuddin Makassar Sulawesi Selatan

Sponsors (2)

Lead Sponsor Collaborator
Nadirah Rasyid Ridha Hasanuddin University

Country where clinical trial is conducted

Indonesia, 

References & Publications (1)

Samson KLI, Fischer JAJ, Roche ML. Iron Status, Anemia, and Iron Interventions and Their Associations with Cognitive and Academic Performance in Adolescents: A Systematic Review. Nutrients. 2022 Jan 5;14(1):224. doi: 10.3390/nu14010224. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary This study was to compare the effect of standard therapy with standard therapy plus vitamin D in children with IDA. Comparing pre-treatment routine blood test, serum iron, and serum ferritin levels between iron supplementation and iron and vitamin D supplementation groups.
Comparing the levels of routine blood tests, serum iron, and serum ferritin results after treatment between iron supplementation and iron and vitamin D supplementation groups.
After 4 weeks
Secondary Comparison of mean changes in complete blood count, serum iron, and serum ferritin level Comparing the difference in routine blood test results, and ferritin before and after treatment between the iron supplementation group and the iron and vitamin D supplementation group.
Comparing the difference of routine blood test results, and serum iron ferritin before and after therapy in the iron supplementation group.
Comparing the difference of routine blood test results, serum iron ferritin before and after therapy in iron supplementation and Vitamin D supplementation groups.
after 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05179226 - Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia Phase 3
Completed NCT05878379 - Effect of a Dietary Iron Program on Iron Status and IQ in Children in Phatthalung Province, Thailand N/A
Completed NCT03181451 - Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency Phase 1
Not yet recruiting NCT03482076 - Iron Deficiency Anemia in Childern With Liver Cirrhosis N/A
Recruiting NCT04095884 - An Observational Study Designed to Elucidate the Pathways by Which Inflammation Contributes to Anaemia in Sick Rural African Children From 6 Months to 36 Months
Completed NCT02941081 - A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial Phase 2